A Groundbreaking Shift in Insulin Accessibility: Evaluating the Impact of the Medicare $35 Cap on Out-of-Pocket Costs The landscape of diabetes management underwent a significant transformation in 2023, driven by a pivotal policy change in Medicare that capped insulin out-of-pocket expenses to $35. This regulatory intervention has ushered in notable improvements in both the affordability and consistency of insulin access among Medicare beneficia…
This story is only covered by news sources that have yet to be evaluated by the independent media monitoring agencies we use to assess the quality and reliability of news outlets on our platform. Learn more here.